Su-Yeon Yu (Su Yeon Yu)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Venues

Scientific reports

PloS one

Journal of Korean medical science

Vaccines

National Evidence-based Healthcare Collaborating Agency

Seoul National University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Evidence-based Healthcare Collaborating Agency

South Korea

Associate Research Fellow :: Healthcare Technology Assessment Research

University of Queensland

Australia

post doctoral researcher :: School of Pharmacy

Education History

Seoul National University

South Korea

MSC :: School of Pharmacy

Seoul National University

South Korea

BSC :: School of Pharmacy

Publications

Woojin Lim, Sungji Moon, Na Rae Lee, Ho Gyun Shin, Su-Yeon Yu, Jung Eun Lee, Inah Kim, Kwang Pil Ko, Sue-Kyung Park
Group I pharmaceuticals of IARC and associated cancer risks: systematic review and meta-analysis. Scientific reports 14 (1) (2024)
Woojin Lim, Sungji Moon, Na Rae Lee, Ho Gyun Shin, Su-Yeon Yu, Jung Eun Lee, Inah Kim, Kwang Pil Ko, Sue-Kyung Park
Group I pharmaceuticals of IARC and associated cancer risks: systematic review and meta-analysis. Scientific reports 14 (1) (2024)
Won Suk Choi, Yeonhee Sung, Jimin Kim, Hyeri Seok, Young J Choe, Chelim Cheong, Jahyun Cho, Dong Woo Lee, Jee Yeon Shin, Su-Yeon Yu
Prioritization of Vaccines for Introduction in the National Immunization Program in the Republic of Korea. Vaccines 12 (8) (2024)
Woojin Lim, Sungji Moon, Na Rae Lee, Ho Gyun Shin, Su-Yeon Yu, Jung Eun Lee, Inah Kim, Kwang Pil Ko, Sue-Kyung Park
Group I pharmaceuticals of IARC and associated cancer risks: systematic review and meta-analysis. Scientific reports 14 (1) (2024)
Woojin Lim, Sungji Moon, Na Rae Lee, Ho Gyun Shin, Su-Yeon Yu, Jung Eun Lee, Inah Kim, Kwang Pil Ko, Sue-Kyung Park
Group I pharmaceuticals of IARC and associated cancer risks: systematic review and meta-analysis. Scientific reports 14 (1) (2024)
Mi-Hai Park, Su-Yeon Yu, Ha Lim Jeon, Inmyung Song
Factors Affecting Health-Related Quality of Life in Patients With Metastatic Breast Cancer. Journal of breast cancer (2023)
Seungeun Ryoo, Dae-Hyup Koh, Su-Yeon Yu, Miyoung Choi, Kyungmin Huh, Joon-Sup Yeom, Jung Yeon Heo
Clinical efficacy and safety of interferon (Type I and Type III) therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. PloS one 18 (3) (2023)
Jimin Kim, Young June Choe, Jungeun Park, Jahyun Cho, Chelim Cheong, Jin Kyoung Oh, Mi-Hai Park, Eunha Shim, Su-Yeon Yu
Comparative Effects of Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines in The Prevention of Genotype-Specific Infection: A Systematic Review and Network Meta-Analysis. Infection & chemotherapy (2023)
Miyoung Choi, Hyeon Jeong Lee, Su-Yeon Yu, Jimin Kim, Jungeun Park, Seungeun Ryoo, Inho Kim, Dong-Ah Park, Young Kyoung Yoon, Joon-Sung Joh, Sunghoon Park, Ki-Wook Yun, Chi-Hoon Choi, Jae Seok Kim, Sue Shin, Hyun Kim, Kyungmin Huh, In Seok Jeong, Soo-Han Choi, Sung Ho Hwang, Hyuk Min Lee, Dong Keon Lee, Hwan Seok Yong, Ho Kee Yum
Two Years of Experience and Methodology of Korean COVID-19 Living Clinical Practice Guideline Development. Journal of Korean medical science 38 (23) (2023)
Seungeun Ryoo, Dae-Hyup Koh, Su-Yeon Yu, Miyoung Choi, Kyungmin Huh, Joon-Sup Yeom, Jung Yeon Heo
Clinical efficacy and safety of interferon (Type I and Type III) therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. PloS one 18 (3) (2023)
Seungeun Ryoo, Dae-Hyup Koh, Su-Yeon Yu, Miyoung Choi, Kyungmin Huh, Joon-Sup Yeom, Jung Yeon Heo
Clinical efficacy and safety of interferon (Type I and Type III) therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. PloS one 18 (3) (2023)
Yan Jin, Jae Hung Jung, Woong Kyu Han, Eu Chang Hwang, Yoonmi Nho, Na Rae Lee, Ji Eun Yun, Kwang-Suk Lee, Sang Hyub Lee, Hakmin Lee, Su-Yeon Yu
Diagnostic accuracy of prostate-specific antigen below 4 ng/mL as a cutoff for diagnosing prostate cancer in a hospital setting: A systematic review and meta-analysis. Investigative and clinical urology 63 (3) (2022)
Su-Yeon Yu, Dae-Hyup Koh, Miyoung Choi, Seungeun Ryoo, Kyungmin Huh, Joon Sup Yeom, Young Kyoung Yoon
Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis. Emerging microbes & infections 11 (1) (2022)
Samantha A Hollingworth, Ama Pokuaa Fenny, Su-Yeon Yu, Francis J Ruiz, Kalipso Chalkidou
Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis. Cost effectiveness and resource allocation : C/E 19 (1) (2021)
Su-Yeon Yu, Dan Mckavanagh, Ian McPherson, Euan Walpole, Victoria Atkinson, Samantha A Hollingworth
Survival of advanced melanoma patients treated with immunotherapy and targeted therapy: A real-world study. Pharmacoepidemiology and drug safety 30 (10) (2021)
Jangmi Yang, Miyoung Choi, Jin A Choi, Minjoo Kang, Ae Jeong Jo, Seung Hyun Chung, Sung Hoon Sim, Yu Jung Kim, Eun Joo Yang, Su-Yeon Yu
Supervised Physical Rehabilitation in the Treatment of Patients with Advanced Cancer: a Systematic Review and Meta-analysis. Journal of Korean medical science 35 (29) (2020)

Su-Yeon Yu.css-eqlu8i{font-size:small;padding-left:4px;} (Su Yeon Yu)

Publication Activity (10 Years)

Top Topics

Top Venues

Su-Yeon Yu (Su Yeon Yu)